Citizens Financial Group’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
VCM
6CM
KGAMU
WPM
RC
QOP
Citizens Financial Group's CDLX Position: Q1 2026 in Review
Citizens Financial Group sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 48,300 shares — an estimated $555K sold.
Citizens Financial Group first reported a position in CDLX in Q3 2025 and held it in 2 quarters. The position peaked at $1.26M in Q3 2025. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.
- Citizens Financial Group reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
- Citizens Financial Group sold 48,300 Cardlytics shares in Q1 2026, an estimated $555K.
- Citizens Financial Group first reported a position in Cardlytics in Q3 2025 and held it in 2 quarters.
- Citizens Financial Group's Cardlytics position peaked at $1.26M in Q3 2025.
- 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.
Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.